Cargando…
Quality comparison of a state-of-the-art preparation of a recombinant L-asparaginase derived from Escherichia coli with an alternative asparaginase product
L-asparaginase (ASNase) is a protein that is essential for the treatment of acute lymphoblastic leukemia (ALL). The main types of ASNase that are clinically used involve native and pegylated Escherichia coli (E. coli)-derived ASNase as well as Erwinia chrysanthemi-derived ASNase. Additionally, a new...
Autores principales: | Schnuchel, Arndt, Radcke, Christoph, Theobald, Lars, Doeding, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270636/ https://www.ncbi.nlm.nih.gov/pubmed/37319282 http://dx.doi.org/10.1371/journal.pone.0285948 |
Ejemplares similares
-
SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE : INCIDENCE OF SENSITIVITY AMONG LEUKEMIAS OF VARIOUS TYPES: COMPARATIVE INHIBITORY ACTIVITIES OF GUINEA PIG SERUML-ASPARAGINASE AND ESCHERICHIA COLI L-ASPARAGINASE
por: Boyse, Edward A., et al.
Publicado: (1967) -
PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020) -
Cloning, expression, purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia coli
por: Pourhossein, Meraj, et al.
Publicado: (2014) -
Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
por: Einsfeldt, Karen, et al.
Publicado: (2016) -
Correction: Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
por: Einsfeldt, Karen, et al.
Publicado: (2016)